Display of HIV-1 Envelope Protein on Lambda Phage Scaffold as a Vaccine Platform

Authors

Jonelle Mattiacio, St. John Fisher UniversityFollow
Matt Brewer, University of Rochester
Stephen Dewhurst, University of Rochester

Document Type

Book Chapter

Publication Date

4-4-2017

Abstract

The generation of a strong antibody response to target antigens is a major goal for vaccine development. Here we describe the display of the human immunodeficiency virus (HIV) envelope spike protein (Env) on a virus-like scaffold provided by the lambda phage capsid. Phage vectors, in general, have advantages over mammalian virus vectors due to their genetic tractability, inexpensive production, suitability for scale-up, as well as their physical stability, making them an attractive vaccine platform.

DOI

https://doi.org/10.1007/978-1-4939-6869-5_14

Comments

Chapter published as: Mattiacio J.L., Brewer M., Dewhurst S. (2017) Display of HIV-1 Envelope Protein on Lambda Phage Scaffold as a Vaccine Platform. In: Ferran M., Skuse G. (eds) Recombinant Virus Vaccines. Methods in Molecular Biology, vol 1581. Humana Press, New York, NY

Find this book at your library.

Buy this book on Amazon.

Publication Information

Mattiacio, Jonelle; Brewer, Matt; and Dewhurst, Stephen (2017). "Display of HIV-1 Envelope Protein on Lambda Phage Scaffold as a Vaccine Platform." Recombinant Virus Vaccines. Methods in Molecular Biology 1581, 245-253.

Please note that the Publication Information provides general citation information and may not be appropriate for your discipline. To receive help in creating a citation based on your discipline, please visit http://libguides.sjfc.edu/citations.